Shingles Vaccine Linked to Reduced Dementia Risk
Protective Benefits for Older Adults
Adults aged 50 and older have the option to protect themselves against shingles through vaccination. Recent studies indicate that the shingles vaccine may provide additional health benefits, particularly in lowering the risk of dementia and heart disease.
New Findings on Vascular Dementia
A recent study presented at IDWeek 2025 reveals a potential connection between the shingles vaccine and a decrease in the risk of vascular dementia. This condition is often associated with cardiovascular events, such as blood clots, heart attacks, and strokes.
Prevalence of Shingles
Researchers estimate that one in three people will develop shingles at some point in their lives. This viral infection leads to an intensely painful rash that can blister. Since 2006, older adults have been encouraged to receive the shingles vaccine as a preventive measure.
CDC Recommendations
The U.S. Centers for Disease Control and Prevention (CDC) recommends that adults aged 50 and over receive two doses of the shingles vaccine to ensure optimal protection.
Previous Research Highlights
Earlier studies have also underscored the vaccine’s potential health benefits. A study published in May 2025 reported a 23% reduction in the risk of cardiovascular events associated with the shingles vaccine. Additionally, research from April 2025 indicated a possible 20% decrease in dementia risk linked to vaccination.
Conclusion
The findings from the latest research further strengthen the notion that the shingles vaccine may play a significant role in enhancing the health of older adults by reducing the risk of vascular dementia and related cardiovascular issues.